TV D21 Pill - blue oval
Pill with imprint TV D21 is Blue, Oval and has been identified as Deferasirox 360 mg. It is supplied by Teva Pharmaceuticals USA, Inc.
Deferasirox is used in the treatment of Iron Overload; Thalassemia; Hemosiderosis and belongs to the drug class chelating agents. Risk cannot be ruled out during pregnancy. Deferasirox 360 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for TV D21
Deferasirox
- Imprint
- TV D21
- Strength
- 360 mg
- Color
- Blue
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Chelating agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA, Inc.
- National Drug Code (NDC)
- 00093-3515 (Discontinued)
See also:
Jadenu
Jadenu (deferasirox) treats iron overload by binding to iron and removing it from the bloodstream ...
Ferriprox
Ferriprox (deferiprone) is used to treat patients with iron overload caused by blood transfusions ...
Tavneos
Tavneos (avacopan) is a C5a receptor antagonist used for severe active ANCA-associated vasculitis ...
Exjade
Exjade is used to treat iron overload caused by blood transfusions. Learn about side effects ...
More about deferasirox
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (5)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: chelating agents
- Breastfeeding
- En español
Patient resources
- Deferasirox drug information
- Deferasirox (Advanced Reading)
- Deferasirox Tablets
- Deferasirox Tablets For Oral Suspension
Other brands
Jadenu, Exjade, Jadenu Sprinkle
Professional resources
- Deferasirox monograph
- Deferasirox (FDA)
- Deferasirox Tablets (FDA)
- Deferasirox Tablets for Suspension (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.